NAGE vs ZTS · P/E 59, rev $61.3M vs P/E 25, rev $2.47B
Niagen Bioscience, Inc. (NAGE) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the NAGE and ZTS stock pages for the full models.
Not investment advice.